Start Date
August 31, 2010
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
lenalidomide
"Patient enrollment FNA of palpable lymph node prior to escalation phase~Escalation phase of Lenalidomide:~Lenalidomide 5 mg daily PO x 14 days Lenalidomide 10 mg daily PO x 14 days Lenalidomide 15 mg daily PO x 14 days Week of rest FNA of palpable lymph node prior to treatment phase~Treatment phase of Lenalidomide:~15 mg daily PO days 1-21 out of a 28 day cycle Repeat x 6 cycles"
Collaborators (1)
Celgene Corporation
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER